Needlestick injuries are a major concern of healthcare workers.  The Canadian Centre for Occupational Health and Safety (CCOHS) indicates that some hospitals report one-third of nursing and laboratory staff suffer needlestick injuries annually.

Direct treatment costs associated with high risk needlestick injury can reach up to $3,000 USD while total treatment costs including staff replacement costs exceed $17,000 USD.

The Center for Disease Control (CDC) in the U.S. estimates 62% to 88% of sharps injuries can potentially be prevented by the use of safer medical devices.

LifeShield® is a broad range of products designed to address caregiver safety issues. Clave® provides true needle-free access to I.V. systems. Hospira's dedication to improving safety in healthcare extends beyond product development and distribution with continuing clinician education.